July 1st, 2015 - West Bend, WI, USA - Spaulding Clinical Research, LLC (SCR), a leading global biopharmaceutical services provider, today announced that the Company had completed an expansion of their Clinical Pharmacology Unit located in West Bend, WI in order to meet growing client demand for expertise-based studies in the early phases of clinical development.
“As biopharmaceutical companies have been conducting more Phase I and Proof-of-Concept studies with increasing complexity, SCR has been well positioned to meet their needs. In this regard, we are a top provider of expertise-based Phase I services and have more than 200 beds, which is among the largest capacities for a single CRO research unit in the world,” said Cassandra Erato, Chief Operating Officer. “With our expansion complete, we are uniquely positioned to provide our customers with a level of flexibility that most units cannot.”
About Spaulding Clinical Research, LCC
Spaulding Clinical Research, LLC (SCR) is a full-service CRO providing Phase I Drug Development and Core ECG Laboratory Services in support of studies throughout all phases of development. SCR operates a 200-bed, fully paperless, Clinical Pharmacology Unit featuring 96, full 12-lead telemetry beds and a 12-bed unit for First-in-Human /SAD/MAD trials.